Litigation Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)
✉ Email this page to a colleague
INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-09-14 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Kevin McNulty |
| Jury Demand | Defendant | Referred To | Cathy L. Waldor |
| Parties | ALVOGEN PINE BROOK LLC | ||
| Patents | 8,475,832; 8,603,514; 9,687,454; 9,855,221; 9,931,305 | ||
| Attorneys | PHILIP SCOTT MAY | ||
| Firms | Saul Ewing Arnstein & Lehr LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in INDIVIOR INC. v. ALVOGEN PINE BROOK, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-10-27 | Judgment of Invalidity of Claim 6 of U.S. Patent No. 9,687,454. Responses due by 11/23/2021 Replies due…14 September 2017 2:17-cv-07106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | ||
| 2017-09-14 | 1 | xpiration ofUnited States Patent No. 9 ,687,454 (“the ’454 patent”or “the patent-in-s uit”). …TH E PATENT-IN-SUIT 9. PlaintiffIndivior UK is the lawfulowne r ofthe ’454 patent,and PlaintiffIndivior… an e xclus ive lice ns e e ofthe ’454 patent.Th e ’454 patent,e ntitled “Sublingualand BuccalFilm Com…ndant. I. COM PLAINT FOR PATENT INFRINGEM ENT Plaintiffs Indivior Inc. (form e… ntaris ing unde r the Food and D rug Laws and PatentLaws ofthe United States , Titles 21 and 35 ofthe | External link to document | |
| 2019-02-26 | 121 | of Dismissal of Claims Relating to U.S. Patent No. 9,855,221. etc. Signed by Judge Kevin McNulty on 2…14 September 2017 2:17-cv-07106 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2019-11-05 | 215 | film is also covered by Patent No. 8,603,514 (“the ‘514 Patent”). The ‘514 Patent shares the same specification…7111 at DE 250-1). “514 Patent” = United States Patent No. 8,603,514, P1. Ex. C (Dkt. No. 7106 at… Alvogen. The patents-in-suit are Patent Nos. 9,931,305 (“the ‘305 Patent”), issued to Aquestive…Aquestive. The patent for that film, the ‘514 Patent, was issued on December 10, 2013.2 (‘514 Patent at [45j…films” in the ‘514 Patent. Id. at 1027. In reviewing the ‘305 Patent and the ‘514 Patent, the Federal Circuit | External link to document | |
| 2019-11-19 | 217 | obtained U.S. Patent Nos. 9,931,305 and 9,687,454 (the “’305 patent” and the “’454 patent,” respectively…events of the above motions. Following a related patent infringement litigation in the District of Delaware…respectively) and subsequently asserted patent infringement claims against DRL and Alvogen in various cases in…Indivior was unlikely to succeed on the merits of its patent infringement claim. Indivior Inc. v. Dr. Reddy’…judgment and forfeiture of various trademarks, patents, assets and receivables. III. DISCUSSION | External link to document | |
| 2018-02-06 | 23 | United States Patent Nos. 9,687,454 (“the ’454 patent”) and 9,855,221 (“the ’221 patent”) (collectively…’221 patent, and Plaintiff Indivior is an exclusive licensee of the ’221 patent. The ’221 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…THE PATENTS-IN-SUIT 11. Plaintiff Indivior UK is the lawful owner of the ’454 patent, and… is an exclusive licensee of the ’454 patent. The ’454 patent, entitled “Sublingual and Buccal Film | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
